"ASXL1"-erating inflammation and bone marrow fibrosis in myeloproliferative neoplasms

被引：0
|
作者：
Gleitz, Helene F. E. [1 ,2 ]
Schneider, Rebekka K. [1 ,2 ,3 ]
机构：
[1] Erasmus MC, Dept Dev Biol, Rotterdam, Netherlands
[2] Oncode Inst, Erasmus Med Ctr, Rotterdam, Netherlands
[3] Rhein Westfalische TH RWTH Aachen Univ, Inst Biomed Engn, Fac Med, Dept Cell Biol, Aachen, Germany
来源：
HAEMATOLOGICA | 2023年 / 108卷 / 05期
关键词：
STROMAL CELLS;
D O I：
10.3324/haematol.2022.281634
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1203 / 1204
页数：2
相关论文
共 50 条
  • [1] Mutations of ASXL1 gene in myeloproliferative neoplasms
    N Carbuccia
    A Murati
    V Trouplin
    M Brecqueville
    J Adélaïde
    J Rey
    W Vainchenker
    O A Bernard
    M Chaffanet
    N Vey
    D Birnbaum
    M J Mozziconacci
    Leukemia, 2009, 23 : 2183 - 2186
  • [2] Mutations of ASXL1 gene in myeloproliferative neoplasms
    Carbuccia, N.
    Murati, A.
    Trouplin, V.
    Brecqueville, M.
    Adelaide, J.
    Rey, J.
    Vainchenker, W.
    Bernard, O. A.
    Chaffanet, M.
    Vey, N.
    Birnbaum, D.
    Mozziconacci, M. J.
    LEUKEMIA, 2009, 23 (11) : 2183 - 2186
  • [3] Disruption of asxl1 results in myeloproliferative neoplasms in zebrafish
    Gjini, Evisa
    Jing, Chang-Bin
    Nguyen, Ashley T.
    Reyon, Deepak
    Gans, Emma
    Kesarsing, Michiel
    Peterson, Joshua
    Pozdnyakova, Olga
    Rodig, Scott J.
    Mansour, Marc R.
    Joung, Keith
    Look, A. Thomas
    DISEASE MODELS & MECHANISMS, 2019, 12 (05)
  • [4] ASXL1 mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms
    Shi, Zhongxun
    Liu, Jinqin
    Zhao, Yingying
    Yang, Lin
    Cai, Yanan
    Zhang, Peihong
    Xu, Zefeng
    Qin, Tiejun
    Qu, Shiqiang
    Pan, Lijuan
    Wu, Junying
    Yan, Xin
    Li, Zexing
    Zhang, Wenjun
    Yan, Yiru
    Huang, Huijun
    Huang, Gang
    Li, Bing
    Wu, Xudong
    Xiao, Zhijian
    HAEMATOLOGICA, 2023, 108 (05) : 1359 - 1373
  • [5] Bone marrow fibrosis, sequence variant of asxl1, and Sjogren syndrome: A case report
    Santaliestra, Marta
    Bussaglia, Elena
    Pratcorona, Marta
    Monter-Rovira, Anna
    Saavedra, Silvana
    Mozos, Anna
    Martinez, Clara
    Nomdedeu, Josep F.
    CLINICAL CASE REPORTS, 2020, 8 (07): : 1269 - 1273
  • [6] Role of TET2 and ASXL1 Mutations in the Pathogenesis of Myeloproliferative Neoplasms
    Abdel-Wahab, Omar
    Mu, Ayalew Tefferi
    Levine, Ross L.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2012, 26 (05) : 1053 - +
  • [7] Prognostic Significance Of ASXL1 and IDH Mutations inPhiladelphia Negative Myeloproliferative Neoplasms
    Yonal, Ipek
    Aday, Aynur Daglar
    Akadam, Aysegul Basak
    Yilmaz, Ceylan
    Nalcaci, Meliha
    Yavuz, Akif Selim
    Sargin, Fatma Deniz
    BLOOD, 2013, 122 (21)
  • [8] Overall Survival in Patients with JAK2 and ASXL1 Positive Myeloproliferative Neoplasms
    Al-Khabori, Murtadha
    Al-Zadjali, Shoaib
    Al Noumani, Iman
    Al Farsi, Khalil
    Al-Kindi, Salam
    Al Huneini, Mohamed
    Fawaz, Naglaa
    Sulayma, Al Lamki
    Al Bulushi, Mahdiya Pir
    Al Hashmi, Khalid
    Al Tarshi, Muna
    Almusalhi, Muhanna
    BLOOD, 2019, 134
  • [9] TET2 and ASXL1 Mutations in Leukemic Transformation of Chronic Myeloproliferative Neoplasms
    Abdel-Wahab, Omar
    Manshouri, Taghi
    Patel, Jay
    Harris, Kelly
    Yao, Jin Juan
    Hedvat, Cyrus V.
    Heguy, Adriana
    Bueso-Ramos, Carlos
    Kantarjian, Hagop M.
    Levine, Ross L.
    Verstovsek, Srdan
    BLOOD, 2009, 114 (22) : 1130 - 1131
  • [10] Altered erythropoiesis via JAK2 and ASXL1 mutations in myeloproliferative neoplasms
    Collinsa, Taylor B.
    Laranjeiraa, Angelo B. A.
    Konga, Tim
    Fulbrighta, Mary C.
    Fishera, Daniel A. C.
    Sturgeona, Christopher M.
    Batistaa, Luis F. Z.
    Oh, Stephen T.
    EXPERIMENTAL HEMATOLOGY, 2024, 132
12345